1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NATCO PHARMA LTD.
Natco Pharma Ltd.
NSE: NATCOPHARM | BSE: 524816
Mid-range Performer
In 2 Starfolio Baskets
Iran War Impact
926.50 -8.00 (-0.86%)
52W high on May 12, 2026
580.5K
NSE+BSE Volume
High vol.+loss this week

NSE 04 Jun, 2026 12:21 PM (IST)

Watchlist

Portfolio

Alert
US FDA Approval
Natco Pharma and partner Lupin get US FDA approval for Natco's ANDA for Eribulin Mesylate Injection See details

Detailed Stock Analysis for Natco Pharma with Real-time Stock Report

Download Sample Report
crown icon
Premium Feature
Please subscribe to GuruQ or StratQ
Subscribe Sign in